Phase I/II Combination Immunotherapy After ASCT for Advanced Myeloma to Study HTERT Vaccination Followed by Adoptive Transfer of Vaccine-Primed Autologous T Cells.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; ITI 1000; Multiple myeloma vaccine; Pneumococcal vaccine
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacodynamics
- 23 Oct 2019 Biomarkers information updated
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.